Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
August 21, 2019
2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth
Deborah A Smithen, Leo M H Leung, Mairi Challinor, et al.
Scientific Reports
|
June 24, 2018
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
Sofia C Nunes, Cristiano Ramos, Filipa Lopes-Coelho, et al.
The Journal of Biological Chemistry
|
July 14, 2006
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation
Nagarajan Vaidehi, Sabine Schlyer, Rene J Trabanino, et al.
Pathogens (Basel, Switzerland)
|
January 25, 2025
Assessment of Antibiotic Resistance Among Isolates of <i>Klebsiella</i> spp. and <i>Raoultella</i> spp. in Wildlife and Their Environment from Portugal: A Positive Epidemiologic Outcome
Carolina Sabença, Rani de la Rivière, Paulo Barros, et al.
Cancer Research
|
October 13, 2019
Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance Elastography
Jin Li, Konstantinos Zormpas-Petridis, Jessica K R Boult, et al.
Journal of Medicinal Chemistry
|
July 6, 2010
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors
Alfonso Zambon, Delphine Ménard, Bart M J M Suijkerbuijk, et al.
Journal of Medicinal Chemistry
|
May 10, 2019
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships
Leo Leung, Dan Niculescu-Duvaz, Deborah Smithen, et al.
Journal of Medicinal Chemistry
|
March 5, 2010
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): increasing cellular potency through optimization of a distal heteroaromatic group
Bart M J M Suijkerbuijk, Ion Niculescu-Duvaz, Catherine Gaulon, et al.
Cancer Cell
|
December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma
Maria Romina Girotti, Filipa Lopes, Natasha Preece, et al.
Cancer Cell
|
July 23, 2021
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Colin Hutton, Felix Heider, Adrian Blanco-Gomez, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
August 21, 2019
2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth
Deborah A Smithen, Leo M H Leung, Mairi Challinor, et al.
Scientific Reports
|
June 24, 2018
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
Sofia C Nunes, Cristiano Ramos, Filipa Lopes-Coelho, et al.
The Journal of Biological Chemistry
|
July 14, 2006
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation
Nagarajan Vaidehi, Sabine Schlyer, Rene J Trabanino, et al.
Pathogens (Basel, Switzerland)
|
January 25, 2025
Assessment of Antibiotic Resistance Among Isolates of <i>Klebsiella</i> spp. and <i>Raoultella</i> spp. in Wildlife and Their Environment from Portugal: A Positive Epidemiologic Outcome
Carolina Sabença, Rani de la Rivière, Paulo Barros, et al.
Cancer Research
|
October 13, 2019
Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance Elastography
Jin Li, Konstantinos Zormpas-Petridis, Jessica K R Boult, et al.
Journal of Medicinal Chemistry
|
July 6, 2010
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors
Alfonso Zambon, Delphine Ménard, Bart M J M Suijkerbuijk, et al.
Journal of Medicinal Chemistry
|
May 10, 2019
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships
Leo Leung, Dan Niculescu-Duvaz, Deborah Smithen, et al.
Journal of Medicinal Chemistry
|
March 5, 2010
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): increasing cellular potency through optimization of a distal heteroaromatic group
Bart M J M Suijkerbuijk, Ion Niculescu-Duvaz, Catherine Gaulon, et al.
Cancer Cell
|
December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma
Maria Romina Girotti, Filipa Lopes, Natasha Preece, et al.
Cancer Cell
|
July 23, 2021
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Colin Hutton, Felix Heider, Adrian Blanco-Gomez, et al.
Page
of 9